Which adverse reactions were most frequently reported as possibly or probably related to emtricitabine/tenofovir disoproxil in the adult HIV-1 treatment study GS-01-934?

In the open-label randomised adult HIV-1 treatment study GS-01-934, nausea (12%) and diarrhoea (7%) were the most frequently reported adverse reactions considered possibly or probably related to emtricitabine and/or tenofovir disoproxil.